---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-003165"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:36:41.246721+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech CMO Lauren Wood retires; Kirk Shepard appointed as new CMO

## Summary
- Lauren V. Wood, M.D. retired as CMO effective January 22, 2024; departure not related to any disagreement.
- Kirk V. Shepard, M.D. appointed as CMO effective January 22, 2024; board-certified oncologist with >30 years industry experience.
- Inducement Plan amended to increase reserved shares from 1,100,000 to 2,100,000 shares of common stock.
- Dr. Shepard granted nonstatutory stock options to purchase 200,000 shares at $4.49 (closing price on grant date).

## SEC filing metadata
- accession: 0001140361-24-003165
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036124003165/0001140361-24-003165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036124003165/ef20019392_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-003165
- JSON: https://secwatch.observer/filing/0001140361-24-003165.json
- Plain text: https://secwatch.observer/filing/0001140361-24-003165.txt

## Key facts
- Executive change
  Lauren V. Wood retired as Chief Medical Officer at PDS Biotechnology Corp.
  - Action: retired
  - Role: Chief Medical Officer
  source text: Effective as of January 22, 2024, Lauren V. Wood, M.D. retired from her position as Chief Medical Officer of PDS Biotechnology Corporation (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036124003165/0001140361-24-003165-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.